Fluoroquinolone is a type of drug used to prevent and treat infections. Fluoroquinolones are associated with an increased risk of tendinitis and tendon rupture. This risk is further increased in those over age 60, in kidney, heart, and lung transplant recipients, and with use of concomitant steroid therapy.
According to the U.S. Centre for Disease Control and Prevention (CDC), gonorrhoea affects as many as 700,000 Americans each year and the sexually transmitted disease has now become so drug resistant doctors are running out of options with which to treat it.
Drug-resistant bacteria can complicate treatment after many surgical procedures.
Drug-resistant TB, including extensively drug-resistant TB, presents significant challenges to treatment and control of the disease in the United States and abroad, according to articles in today's "Morbidity and Mortality Weekly Report" (MMWR).
Health experts have confirmed that the emergence of extensively drug-resistant tuberculosis (XDR-TB) poses a serious threat to public health, particularly when associated with HIV.
Researchers in the U.S. say that methicillin-resistant Staphylococcus aureus or MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country.
Australia's policy of restricting antibiotic use in food-producing animals may be linked with lower levels of drug-resistant bacteria found in its citizens, according to an article in the May 15 issue of Clinical Infectious Diseases.
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
Scientists at the Albert Einstein College of Medicine have discovered a novel strategy by which the bacterium that causes tuberculosis may soon be able to resist the effects of antibiotics known as fluoroquinolones.
Taking antibiotics weekly for one year does not reduce the risk of a heart attack or other cardiac event for patients with stable coronary artery disease, according to a study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. It is published in the April 21, 2005, edition of the New England Journal of Medicine.
The presence of drug-resistant, pathogenic bacteria on uncooked poultry products varies by commercial brand and is likely related to antibiotic use in production, according to researchers at the Johns Hopkins Bloomberg School of Public Health.
A three-day regimen of the antibiotic amoxicillin-clavulanate is not as effective as ciprofloxacin at treating an uncomplicated bladder infection in women, according to a study conducted by Thomas M. Hooton, M.D., of the University of Washington and Harborview Medical Center, Seattle, and colleagues.
Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.
In response to a recent increase in drug resistant gonorrhea, the New York Department of Health and Mental Hygiene (DOHMH) is issuing a health alert to New York City medical providers announcing alternative treatment recommendations for individuals infected with gonorrhea.
The increasing resistance to fluoroquinolones effectively eliminates an entire class of antibiotics and leaves only one class of drugs -- cephalosporins -- as the first-line therapy in the treatment of gonorrhea. There are currently no other major groups of antibiotics left to treat gonorrhea.